BMI ≥ 35 with significant comorbidity (T2DM, severe sleep apnoea, MASLD with fibrosis) or BMI ≥ 40 has the strongest evidence for surgical durability. Many patients trial GLP-1 first; for severe disease, surgery typically delivers larger and more durable weight loss.
Have a follow-up question?
Reply via the quote wizard with case-specific questions and a coordinator will answer in 1–2 business days.